(Q39367181)

11 September 2017

Pancreatectomised man: A model for diabetes without glucagon (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55531

9 April 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55531

9 April 2022

author name string

A. J. Barnes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55531

9 April 2022

S. R. Bloom

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55531

9 April 2022

language of work or name

English

0 references

publication date

1 January 1976

1 reference

11 September 2017

31 January 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=55531

full work available at URL

9 April 2022

https://api.elsevier.com/content/article/PII:S0140673676913398?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(76)91339-8

https://api.elsevier.com/content/article/PII:S0140673676913398?httpAccept=text/plain

9 April 2022

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(76)91339-8

9 April 2022

1 reference

11 September 2017

1

1 reference

11 September 2017

219-221

1 reference

11 September 2017

7953

1 reference

The essential role of glucagon in the pathogenesis of diabetes mellitus

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Glucagon physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Persistent Pancreatic Glucagon but not Insulin Response to Arginine in Pancreatectomized Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Identification of glucagon in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Modification of the cerebrovascular response to noradrenaline by bile duct ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Hormones of the gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Studies of Glucagon Secretion in Pancreatectomized Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Diabetes following total pancreatectomy; clinical observations of ten cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

FATAL DIABETIC GLOMERULOSCLEROSIS AFTER TOTAL PANCREATECTOMY

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Is glucagon important in stable insulin-dependent diabetics?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Total pancreatectomy for carcinoma of the pancreas in a diabetic person

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Observations on some metabolic changes after total pancreatoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Insulin-resistant diabetes after total pancreatectomy; report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Inhibition of insulin secretion by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Direct inhibition of gastric acid by growth-hormone release-inhibiting hormone in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Direct inhibition of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Editorial: Somatostatin leads to glucagon's renaissance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991339-8

7 January 2021

Journal of Clinical Investigation

5

53

28

Goodner

1974

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(76)91339-8

9 April 2022

14

32

735

Burton

1957

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(76)91339-8

9 April 2022

Identifiers

1 reference

11 September 2017

1 reference